KY SB106 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 5 2019 - 25% progression, died in committee
Action: 2019-02-08 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Amend KRS 218A.172 to add issues that a practitioner is required to discuss with a patient prior to prescribing or dispensing a controlled substance to a patient; require that the same information is discussed prior to a third sequential prescription; require any discussion records to be kept by the practitioner.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to discussion with patients on the risks, benefits, and limitations of treatment with controlled substances.

Sponsors


History

DateChamberAction
2019-02-08Senateto Health & Welfare (S)
2019-02-05Senateintroduced in Senate

Subjects


Kentucky State Sources


Bill Comments

feedback